-
1
-
-
50249099816
-
Metabolic phenotyping in health and disease
-
Holmes E., Wilson I.D., Nicholson J.K. Metabolic phenotyping in health and disease. Cell 2008, 134:714-717.
-
(2008)
Cell
, vol.134
, pp. 714-717
-
-
Holmes, E.1
Wilson, I.D.2
Nicholson, J.K.3
-
2
-
-
33750719994
-
Global systems biology, personalized medicine and molecular epidemiology
-
Nicholson J.K. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2006, 2:52.
-
(2006)
Mol Syst Biol
, vol.2
, pp. 52
-
-
Nicholson, J.K.1
-
3
-
-
84883158538
-
Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases
-
Gomez-Casati D.F., Zanor M.I., Busi M.V. Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int 2013, 7925-7927.
-
(2013)
Biomed Res Int
, pp. 7925-7927
-
-
Gomez-Casati, D.F.1
Zanor, M.I.2
Busi, M.V.3
-
4
-
-
84904116803
-
Microbial metabolomics: innovation, application, insight
-
Aldridge B.B., Rhee K.Y. Microbial metabolomics: innovation, application, insight. Curr Opin Microbiol 2014, 19:90-96.
-
(2014)
Curr Opin Microbiol
, vol.19
, pp. 90-96
-
-
Aldridge, B.B.1
Rhee, K.Y.2
-
5
-
-
84906075660
-
An emerging role for metabolomics in nutrition science
-
Astarita G., Langridge J. An emerging role for metabolomics in nutrition science. J Nutrigenet Nutrigenomics 2013, 6:181-200.
-
(2013)
J Nutrigenet Nutrigenomics
, vol.6
, pp. 181-200
-
-
Astarita, G.1
Langridge, J.2
-
6
-
-
84885964577
-
Review: toxicometabolomics
-
Bouhifd M., Hartung T., Hogberg H.T., Kleensang A., Zhao L. Review: toxicometabolomics. J Appl Toxicol 2013, 33:1365-1383.
-
(2013)
J Appl Toxicol
, vol.33
, pp. 1365-1383
-
-
Bouhifd, M.1
Hartung, T.2
Hogberg, H.T.3
Kleensang, A.4
Zhao, L.5
-
7
-
-
33846977711
-
Metabonomics in pharmaceutical R&D
-
Lindon J.C., Holmes E., Nicholson J.K. Metabonomics in pharmaceutical R&D. FEBS J 2007, 274:1140-1151.
-
(2007)
FEBS J
, vol.274
, pp. 1140-1151
-
-
Lindon, J.C.1
Holmes, E.2
Nicholson, J.K.3
-
8
-
-
84892374338
-
Biomarkers in pharmacology and drug discovery
-
Anderson D.C., Kodukula K. Biomarkers in pharmacology and drug discovery. Biochem Pharmacol 2014, 87:172-188.
-
(2014)
Biochem Pharmacol
, vol.87
, pp. 172-188
-
-
Anderson, D.C.1
Kodukula, K.2
-
9
-
-
84887145976
-
Human metabolomics: strategies to understand biology
-
Ramautar R., Berger R., van der Greef J., Hankemeier T. Human metabolomics: strategies to understand biology. Curr Opin Chem Biol 2013, 17:841-846.
-
(2013)
Curr Opin Chem Biol
, vol.17
, pp. 841-846
-
-
Ramautar, R.1
Berger, R.2
van der Greef, J.3
Hankemeier, T.4
-
10
-
-
84889591862
-
Metabolomics in cancer biomarker discovery: current trends and future perspectives
-
Armitage E.G., Barbas C. Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal 2014, 87:1-11.
-
(2014)
J Pharm Biomed Anal
, vol.87
, pp. 1-11
-
-
Armitage, E.G.1
Barbas, C.2
-
11
-
-
13244266921
-
Lead- and drug-like compounds: the rule-of-five revolution
-
Lipinski C.A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004, 1:337-341.
-
(2004)
Drug Discov Today Technol
, vol.1
, pp. 337-341
-
-
Lipinski, C.A.1
-
12
-
-
24944547571
-
Why drugs fail-a study on side effects in new chemical entities
-
Schuster D., Laggner C., Langer T. Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des 2005, 11:3545-3559.
-
(2005)
Curr Pharm Des
, vol.11
, pp. 3545-3559
-
-
Schuster, D.1
Laggner, C.2
Langer, T.3
-
13
-
-
84857784212
-
Cancer biomarkers: selecting the right drug for the right patient
-
Kelloff G.J., Sigman C.C. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 2012, 11:201-214.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 201-214
-
-
Kelloff, G.J.1
Sigman, C.C.2
-
14
-
-
84858631197
-
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets
-
Corona G., Rizzolio F., Giordano A., Toffoli G. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. J Cell Physiol 2012, 227:2827-2831.
-
(2012)
J Cell Physiol
, vol.227
, pp. 2827-2831
-
-
Corona, G.1
Rizzolio, F.2
Giordano, A.3
Toffoli, G.4
-
15
-
-
79953646618
-
Metabolomics and its practical value in pharmaceutical industry
-
Wei R. Metabolomics and its practical value in pharmaceutical industry. Curr Drug Metab 2011, 12:345-358.
-
(2011)
Curr Drug Metab
, vol.12
, pp. 345-358
-
-
Wei, R.1
-
16
-
-
84871721219
-
Metabolomics and its potential in drug development
-
Beyoglu D., Idle J.R. Metabolomics and its potential in drug development. Biochem Pharmacol 2013, 85:12-20.
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 12-20
-
-
Beyoglu, D.1
Idle, J.R.2
-
17
-
-
84908341419
-
Metabolomics in cell culture-a strategy to study crucial metabolic pathways in cancer development and the response to treatment
-
Halama A. Metabolomics in cell culture-a strategy to study crucial metabolic pathways in cancer development and the response to treatment. Arch Biochem Biophys 2014, 10.1016/j.abb.2014.09.002.
-
(2014)
Arch Biochem Biophys
-
-
Halama, A.1
-
18
-
-
84919460853
-
Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis
-
Eoh H. Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2014, 10.1016/j.tube.2014.08.002.
-
(2014)
Tuberculosis (Edinb)
-
-
Eoh, H.1
-
19
-
-
79952937101
-
H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples
-
Stenman K., Stattin P., Stenlund H., Riklund K., Grobner G., Bergh A. H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples. Biomark Insights 2011, 6:39-47.
-
(2011)
Biomark Insights
, vol.6
, pp. 39-47
-
-
Stenman, K.1
Stattin, P.2
Stenlund, H.3
Riklund, K.4
Grobner, G.5
Bergh, A.6
-
20
-
-
84883482030
-
Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission
-
Puchades-Carrasco L., Lecumberri R., Martinez-Lopez J., Lahuerta J.J., Mateos M.V., Prosper F., San-Miguel J.F., Pineda-Lucena A. Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission. Clin Cancer Res 2013, 19:4770-4779.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4770-4779
-
-
Puchades-Carrasco, L.1
Lecumberri, R.2
Martinez-Lopez, J.3
Lahuerta, J.J.4
Mateos, M.V.5
Prosper, F.6
San-Miguel, J.F.7
Pineda-Lucena, A.8
-
21
-
-
77950944945
-
Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups
-
MacIntyre D.A., Jimenez B., Lewintre E.J., Martin C.R., Schafer H., Ballesteros C.G., Mayans J.R., Spraul M., Garcia-Conde J., Pineda-Lucena A. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 2010, 24:788-797.
-
(2010)
Leukemia
, vol.24
, pp. 788-797
-
-
MacIntyre, D.A.1
Jimenez, B.2
Lewintre, E.J.3
Martin, C.R.4
Schafer, H.5
Ballesteros, C.G.6
Mayans, J.R.7
Spraul, M.8
Garcia-Conde, J.9
Pineda-Lucena, A.10
-
22
-
-
84877767813
-
Biomarkers of food intake and metabolite differences between plasma and red blood cell matrices; a human metabolomic profile approach
-
Catalan U., Rodriguez M.A., Ras M.R., Macia A., Mallol R., Vinaixa M., Fernandez-Castillejo S., Valls R.M., Pedret A., Griffin J.L., et al. Biomarkers of food intake and metabolite differences between plasma and red blood cell matrices; a human metabolomic profile approach. Mol Biosyst 2013, 9:1411-1422.
-
(2013)
Mol Biosyst
, vol.9
, pp. 1411-1422
-
-
Catalan, U.1
Rodriguez, M.A.2
Ras, M.R.3
Macia, A.4
Mallol, R.5
Vinaixa, M.6
Fernandez-Castillejo, S.7
Valls, R.M.8
Pedret, A.9
Griffin, J.L.10
-
23
-
-
84879328712
-
Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes
-
Diaz S.O., Barros A.S., Goodfellow B.J., Duarte I.F., Galhano E., Pita C., Almeida Mdo C., Carreira I.M., Gil A.M. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res 2013, 12:2946-2957.
-
(2013)
J Proteome Res
, vol.12
, pp. 2946-2957
-
-
Diaz, S.O.1
Barros, A.S.2
Goodfellow, B.J.3
Duarte, I.F.4
Galhano, E.5
Pita, C.6
Almeida Mdo, C.7
Carreira, I.M.8
Gil, A.M.9
-
24
-
-
84858064590
-
UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers
-
Graca G., Goodfellow B.J., Barros A.S., Diaz S., Duarte I.F., Spagou K., Veselkov K., Want E.J., Lindon J.C., Carreira I.M., et al. UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol Biosyst 2012, 8:1243-1254.
-
(2012)
Mol Biosyst
, vol.8
, pp. 1243-1254
-
-
Graca, G.1
Goodfellow, B.J.2
Barros, A.S.3
Diaz, S.4
Duarte, I.F.5
Spagou, K.6
Veselkov, K.7
Want, E.J.8
Lindon, J.C.9
Carreira, I.M.10
-
25
-
-
84898728770
-
Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease
-
Blasco H., Nadal-Desbarats L., Pradat P.F., Gordon P.H., Antar C., Veyrat-Durebex C., Moreau C., Devos D., Mavel S., Emond P., et al. Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease. Neurology 2014, 82:1167-1174.
-
(2014)
Neurology
, vol.82
, pp. 1167-1174
-
-
Blasco, H.1
Nadal-Desbarats, L.2
Pradat, P.F.3
Gordon, P.H.4
Antar, C.5
Veyrat-Durebex, C.6
Moreau, C.7
Devos, D.8
Mavel, S.9
Emond, P.10
-
26
-
-
0036707428
-
Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies
-
Keun H.C., Beckonert O., Griffin J.L., Richter C., Moskau D., Lindon J.C., Nicholson J.K. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem 2002, 74:4588-4593.
-
(2002)
Anal Chem
, vol.74
, pp. 4588-4593
-
-
Keun, H.C.1
Beckonert, O.2
Griffin, J.L.3
Richter, C.4
Moskau, D.5
Lindon, J.C.6
Nicholson, J.K.7
-
27
-
-
66749118301
-
Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents
-
Waldram A., Holmes E., Wang Y., Rantalainen M., Wilson I.D., Tuohy K.M., McCartney A.L., Gibson G.R., Nicholson J.K. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 2009, 8:2361-2375.
-
(2009)
J Proteome Res
, vol.8
, pp. 2361-2375
-
-
Waldram, A.1
Holmes, E.2
Wang, Y.3
Rantalainen, M.4
Wilson, I.D.5
Tuohy, K.M.6
McCartney, A.L.7
Gibson, G.R.8
Nicholson, J.K.9
-
28
-
-
80051682403
-
Advances in metabolite identification
-
Wishart D.S. Advances in metabolite identification. Bioanalysis 2011, 3:1769-1782.
-
(2011)
Bioanalysis
, vol.3
, pp. 1769-1782
-
-
Wishart, D.S.1
-
29
-
-
78650761774
-
Nanostructure-initiator mass spectrometry metabolite analysis and imaging
-
Greving M.P., Patti G.J., Siuzdak G. Nanostructure-initiator mass spectrometry metabolite analysis and imaging. Anal Chem 2011, 83:2-7.
-
(2011)
Anal Chem
, vol.83
, pp. 2-7
-
-
Greving, M.P.1
Patti, G.J.2
Siuzdak, G.3
-
30
-
-
17444404226
-
High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies
-
Wilson I.D., Nicholson J.K., Castro-Perez J., Granger J.H., Johnson K.A., Smith B.W., Plumb R.S. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 2005, 4:591-598.
-
(2005)
J Proteome Res
, vol.4
, pp. 591-598
-
-
Wilson, I.D.1
Nicholson, J.K.2
Castro-Perez, J.3
Granger, J.H.4
Johnson, K.A.5
Smith, B.W.6
Plumb, R.S.7
-
31
-
-
84878940718
-
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases
-
Wheelock C.E., Goss V.M., Balgoma D., Nicholas B., Brandsma J., Skipp P.J., Snowden S., Burg D., D'Amico A., Horvath I., et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013, 42:802-825.
-
(2013)
Eur Respir J
, vol.42
, pp. 802-825
-
-
Wheelock, C.E.1
Goss, V.M.2
Balgoma, D.3
Nicholas, B.4
Brandsma, J.5
Skipp, P.J.6
Snowden, S.7
Burg, D.8
D'Amico, A.9
Horvath, I.10
-
32
-
-
84867250802
-
Application of NMR metabolomics to search for human disease biomarkers
-
Gebregiworgis T., Powers R. Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High Throughput Screen 2013, 15:595-610.
-
(2013)
Comb Chem High Throughput Screen
, vol.15
, pp. 595-610
-
-
Gebregiworgis, T.1
Powers, R.2
-
33
-
-
34249890793
-
Metabolomics as a complementary tool in cell culture
-
Khoo S.H., Al-Rubeai M. Metabolomics as a complementary tool in cell culture. Biotechnol Appl Biochem 2007, 47:71-84.
-
(2007)
Biotechnol Appl Biochem
, vol.47
, pp. 71-84
-
-
Khoo, S.H.1
Al-Rubeai, M.2
-
34
-
-
84867434804
-
Metabolomics in drug target discovery
-
Rabinowitz J.D., Purdy J.G., Vastag L., Shenk T., Koyuncu E. Metabolomics in drug target discovery. Cold Spring Harb Symp Quant Biol 2011, 76:235-246.
-
(2011)
Cold Spring Harb Symp Quant Biol
, vol.76
, pp. 235-246
-
-
Rabinowitz, J.D.1
Purdy, J.G.2
Vastag, L.3
Shenk, T.4
Koyuncu, E.5
-
35
-
-
84865096779
-
Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine
-
McNamara L.E., Sjostrom T., Meek R.M., Oreffo R.O., Su B., Dalby M.J., Burgess K.E. Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine. J R Soc Interface 2012, 9:1713-1724.
-
(2012)
J R Soc Interface
, vol.9
, pp. 1713-1724
-
-
McNamara, L.E.1
Sjostrom, T.2
Meek, R.M.3
Oreffo, R.O.4
Su, B.5
Dalby, M.J.6
Burgess, K.E.7
-
36
-
-
84860424349
-
Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis
-
Sonkar K., Purusottam R.N., Sinha N. Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis. Anal Chem 2012, 84:4063-4070.
-
(2012)
Anal Chem
, vol.84
, pp. 4063-4070
-
-
Sonkar, K.1
Purusottam, R.N.2
Sinha, N.3
-
37
-
-
84905046901
-
The current state of drug discovery and a potential role for NMR metabolomics
-
Powers R. The current state of drug discovery and a potential role for NMR metabolomics. J Med Chem 2014, 57:5860-5870.
-
(2014)
J Med Chem
, vol.57
, pp. 5860-5870
-
-
Powers, R.1
-
38
-
-
84897137550
-
Novel next-generation sequencing and networks-based therapeutic targets: realistic and more effective drug design and discovery
-
Roukos D.H., Baltogiannis G.G., Katsouras C.S., Bechlioulis A., Naka K.K., Batsis C., Liakakos T., Michalis L.K. Novel next-generation sequencing and networks-based therapeutic targets: realistic and more effective drug design and discovery. Curr Pharm Des 2014, 20:11-22.
-
(2014)
Curr Pharm Des
, vol.20
, pp. 11-22
-
-
Roukos, D.H.1
Baltogiannis, G.G.2
Katsouras, C.S.3
Bechlioulis, A.4
Naka, K.K.5
Batsis, C.6
Liakakos, T.7
Michalis, L.K.8
-
39
-
-
84883452088
-
Applications of metabolomics in drug discovery, development and theranostics
-
Cuperlovic-Culf M., Culf A.S., Morin P.J., Touaibia M. Applications of metabolomics in drug discovery, development and theranostics. Curr Metab 2013, 1:41-57.
-
(2013)
Curr Metab
, vol.1
, pp. 41-57
-
-
Cuperlovic-Culf, M.1
Culf, A.S.2
Morin, P.J.3
Touaibia, M.4
-
40
-
-
84888011244
-
Network-based approaches in drug discovery and early development
-
Harrold J.M., Ramanathan M., Mager D.E. Network-based approaches in drug discovery and early development. Clin Pharmacol Ther 2013, 94:651-658.
-
(2013)
Clin Pharmacol Ther
, vol.94
, pp. 651-658
-
-
Harrold, J.M.1
Ramanathan, M.2
Mager, D.E.3
-
41
-
-
84855870922
-
Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach
-
Wang X., Yang B., Zhang A., Sun H., Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics 2012, 75:1411-1427.
-
(2012)
J Proteomics
, vol.75
, pp. 1411-1427
-
-
Wang, X.1
Yang, B.2
Zhang, A.3
Sun, H.4
Yan, G.5
-
42
-
-
84890499902
-
Metabolomics reveal d-alanine:d-alanine ligase as the target of d-cycloserine in Mycobacterium tuberculosis
-
Prosser G.A., de Carvalho L.P. Metabolomics reveal d-alanine:d-alanine ligase as the target of d-cycloserine in Mycobacterium tuberculosis. ACS Med Chem Lett 2013, 4:1233-1237.
-
(2013)
ACS Med Chem Lett
, vol.4
, pp. 1233-1237
-
-
Prosser, G.A.1
de Carvalho, L.P.2
-
43
-
-
34548065407
-
Application of metabonomics in drug development
-
Keun H.C., Athersuch T.J. Application of metabonomics in drug development. Pharmacogenomics 2007, 8:731-741.
-
(2007)
Pharmacogenomics
, vol.8
, pp. 731-741
-
-
Keun, H.C.1
Athersuch, T.J.2
-
44
-
-
38049041308
-
Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase
-
Halouska S., Chacon O., Fenton R.J., Zinniel D.K., Barletta R.G., Powers R. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res 2007, 6:4608-4614.
-
(2007)
J Proteome Res
, vol.6
, pp. 4608-4614
-
-
Halouska, S.1
Chacon, O.2
Fenton, R.J.3
Zinniel, D.K.4
Barletta, R.G.5
Powers, R.6
-
45
-
-
84856162572
-
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
-
Halouska S., Fenton R.J., Barletta R.G., Powers R. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol 2012, 7:166-171.
-
(2012)
ACS Chem Biol
, vol.7
, pp. 166-171
-
-
Halouska, S.1
Fenton, R.J.2
Barletta, R.G.3
Powers, R.4
-
46
-
-
34548730771
-
Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles
-
Slupsky C.M., Rankin K.N., Wagner J., Fu H., Chang D., Weljie A.M., Saude E.J., Lix B., Adamko D.J., Shah S., et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 2007, 79:6995-7004.
-
(2007)
Anal Chem
, vol.79
, pp. 6995-7004
-
-
Slupsky, C.M.1
Rankin, K.N.2
Wagner, J.3
Fu, H.4
Chang, D.5
Weljie, A.M.6
Saude, E.J.7
Lix, B.8
Adamko, D.J.9
Shah, S.10
-
47
-
-
84874417316
-
Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study
-
Xu T., Holzapfel C., Dong X., Bader E., Yu Z., Prehn C., Perstorfer K., Jaremek M., Roemisch-Margl W., Rathmann W., et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med 2013, 11:60.
-
(2013)
BMC Med
, vol.11
, pp. 60
-
-
Xu, T.1
Holzapfel, C.2
Dong, X.3
Bader, E.4
Yu, Z.5
Prehn, C.6
Perstorfer, K.7
Jaremek, M.8
Roemisch-Margl, W.9
Rathmann, W.10
-
48
-
-
84893490530
-
Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling
-
Kamlage B., Maldonado S.G., Bethan B., Peter E., Schmitz O., Liebenberg V., Schatz P. Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 2014, 60:399-412.
-
(2014)
Clin Chem
, vol.60
, pp. 399-412
-
-
Kamlage, B.1
Maldonado, S.G.2
Bethan, B.3
Peter, E.4
Schmitz, O.5
Liebenberg, V.6
Schatz, P.7
-
49
-
-
84893302825
-
Human plasma stability during handling and storage: impact on NMR metabolomics
-
Pinto J., Domingues M.R., Galhano E., Pita C., Almeida Mdo C., Carreira I.M., Gil A.M. Human plasma stability during handling and storage: impact on NMR metabolomics. Analyst 2014, 139:1168-1177.
-
(2014)
Analyst
, vol.139
, pp. 1168-1177
-
-
Pinto, J.1
Domingues, M.R.2
Galhano, E.3
Pita, C.4
Almeida Mdo, C.5
Carreira, I.M.6
Gil, A.M.7
-
50
-
-
84908566336
-
Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease
-
Deja S., Porebska I., Kowal A., Zabek A., Barg W., Pawelczyk K., Stanimirova I., Daszykowski M., Korzeniewska A., Jankowska R., et al. Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. J Pharm Biomed Anal 2014, 100:369-380.
-
(2014)
J Pharm Biomed Anal
, vol.100
, pp. 369-380
-
-
Deja, S.1
Porebska, I.2
Kowal, A.3
Zabek, A.4
Barg, W.5
Pawelczyk, K.6
Stanimirova, I.7
Daszykowski, M.8
Korzeniewska, A.9
Jankowska, R.10
-
51
-
-
84868095958
-
A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis
-
Dutta M., Joshi M., Srivastava S., Lodh I., Chakravarty B., Chaudhury K. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst 2012, 8:3281-3287.
-
(2012)
Mol Biosyst
, vol.8
, pp. 3281-3287
-
-
Dutta, M.1
Joshi, M.2
Srivastava, S.3
Lodh, I.4
Chakravarty, B.5
Chaudhury, K.6
-
52
-
-
84892153260
-
Applications of metabolomics in cancer research
-
Vermeersch K.A., Styczynski M.P. Applications of metabolomics in cancer research. J Carcinog 2013, 12:9.
-
(2013)
J Carcinog
, vol.12
, pp. 9
-
-
Vermeersch, K.A.1
Styczynski, M.P.2
-
53
-
-
80655131103
-
The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples
-
Bernini P., Bertini I., Luchinat C., Tenori L., Tognaccini A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples. J Proteome Res 2011, 10:4983-4992.
-
(2011)
J Proteome Res
, vol.10
, pp. 4983-4992
-
-
Bernini, P.1
Bertini, I.2
Luchinat, C.3
Tenori, L.4
Tognaccini, A.5
-
54
-
-
84921759167
-
The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis
-
Nobakht M.G.B.F., Aliannejad R., Rezaei-Tavirani M., Taheri S., Oskouie A.A. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers 2014, 18:1-12.
-
(2014)
Biomarkers
, vol.18
, pp. 1-12
-
-
Nobakht, M.G.B.F.1
Aliannejad, R.2
Rezaei-Tavirani, M.3
Taheri, S.4
Oskouie, A.A.5
-
55
-
-
84155191018
-
Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study
-
Sengupta A., Ghosh S., Basant A., Malusare S., Johri P., Pathak S., Sharma S., Sonawat H.M. Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study. Malar J 2011, 10:384.
-
(2011)
Malar J
, vol.10
, pp. 384
-
-
Sengupta, A.1
Ghosh, S.2
Basant, A.3
Malusare, S.4
Johri, P.5
Pathak, S.6
Sharma, S.7
Sonawat, H.M.8
-
56
-
-
84862623984
-
The role of metabolomics in neurological disease
-
Hassan-Smith G., Wallace G.R., Douglas M.R., Sinclair A.J. The role of metabolomics in neurological disease. J Neuroimmunol 2012, 248:48-52.
-
(2012)
J Neuroimmunol
, vol.248
, pp. 48-52
-
-
Hassan-Smith, G.1
Wallace, G.R.2
Douglas, M.R.3
Sinclair, A.J.4
-
57
-
-
84860492297
-
The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities
-
De Palma M., Hanahan D. The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol Oncol 2012, 6:111-127.
-
(2012)
Mol Oncol
, vol.6
, pp. 111-127
-
-
De Palma, M.1
Hanahan, D.2
-
58
-
-
84893763297
-
Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology
-
Kaddurah-Daouk R., Weinshilboum R.M. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther 2014, 95:154-167.
-
(2014)
Clin Pharmacol Ther
, vol.95
, pp. 154-167
-
-
Kaddurah-Daouk, R.1
Weinshilboum, R.M.2
-
59
-
-
84872028171
-
New opportunities from the cancer metabolome
-
Aboud O.A., Weiss R.H. New opportunities from the cancer metabolome. Clin Chem 2013, 59:138-146.
-
(2013)
Clin Chem
, vol.59
, pp. 138-146
-
-
Aboud, O.A.1
Weiss, R.H.2
-
60
-
-
84896104682
-
Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancer
-
Huang G., Liu X., Jiao L., Xu C., Zhang Z., Wang L., Li Y., Yang C., Zhang W., Sun Y. Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancer. Eur J Pharmacol 2014, 729:132-137.
-
(2014)
Eur J Pharmacol
, vol.729
, pp. 132-137
-
-
Huang, G.1
Liu, X.2
Jiao, L.3
Xu, C.4
Zhang, Z.5
Wang, L.6
Li, Y.7
Yang, C.8
Zhang, W.9
Sun, Y.10
-
61
-
-
84858274873
-
Bridging the gap: moving predictive and prognostic assays from research to clinical use
-
Williams P.M., Lively T.G., Jessup J.M., Conley B.A. Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res 2012, 18:1531-1539.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1531-1539
-
-
Williams, P.M.1
Lively, T.G.2
Jessup, J.M.3
Conley, B.A.4
-
62
-
-
38949209075
-
NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology
-
Coen M., Holmes E., Lindon J.C., Nicholson J.K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008, 21:9-27.
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 9-27
-
-
Coen, M.1
Holmes, E.2
Lindon, J.C.3
Nicholson, J.K.4
-
63
-
-
84866986415
-
Pharmaceutical research and metabolomics in the newborn
-
Antonucci R., Pilloni M.D., Atzori L., Fanos V. Pharmaceutical research and metabolomics in the newborn. J Matern Fetal Neonatal Med 2012, 25:22-26.
-
(2012)
J Matern Fetal Neonatal Med
, vol.25
, pp. 22-26
-
-
Antonucci, R.1
Pilloni, M.D.2
Atzori, L.3
Fanos, V.4
|